Enhanced pathogenesis, and particularly anemia, in the context of elevated IFN-γ is consistent with murine studies showing that treatment with CpG-ODN [30] and acute toxoplasmosis [31] cause increased IFN-γ levels that appear to contribute to suppression of erythropoiesis. Here, IFNG is linked to anemia.